IN
Intelligent Bio Solutions Inc.
INBS · NASDAQ
$1.91 -1.55% (-$0.03)
1M -26.42%
Market Cap $1.29M
P/E Ratio -
Div. Yield -
ROE 170.37%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.23x
P/S 0.31x
PEG N/A
Growth
99 /100
Growing Book val. growth 13.20%
Rev. growth 49.68%
FCF growth N/A
Profitability
19 /100
Weak FCF margin 289.53%
Op. margin 299.11%
Gross margin 48.63%
Quality
4 /100
Poor Asset turnover 0.35x
ROA 104.10%
ROIC 176.09%
Debt
61 /100
Moderate Current ratio 1.44x
Int. coverage -1,160.39x
Debt/Equity 0.33x
Stability
31 /100
Unstable Profitable years 0
EPS volatility 14.63%
Beta 4.25x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre INBS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Harry Simeonidis
Employees
58
Headquarters
New York City
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report